Though the 2014 ebola outbreak has been relatively contained, there is still no vaccine or treatment specifically built for the disease. Since the drug development process can take over a decade, medical personnel faced with emergency outbreaks often face this problem. However, repurposing research at the US Army Medical Research Institute of Infectious Diseases has revealed that two drugs already on pharmacy shelves may be effective ebola treatments. Zoloft, an antidepressant, and Vascor, a chest pain drug that is no longer sold in the United States, both showed potential for treating ebola in humans. Clinical trials have not yet begun, but researchers believe that the repurposed drugs show promise in combatting this dangerous condition.

See article in Science Translational Medicine here